(redirected from Lomefloxacin)
Also found in: Dictionary, Medical, Legal, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for antibiotic

References in periodicals archive ?
Minimum inhibitory concentration (MIC) of isolates (n=80) for ciprofloxacin, ofloxacin and lomefloxacin Antibiotics Distribution of MIC ([micro]g/ml) 0.
Ciprofloxacin and lomefloxacin (IS) were made up as 1 g/L stock solutions in methanol and distilled water (1:10, by volume).
18] The half-life of lomefloxacin in patients with normal renal function is 8 hours; however, it is 21 hours in patients with creatinine clearances of 10 to 40 mL per minute, and 38 to 44 hours in patients with creatinine clearances < 10 mL per minute.
Wang, A novel spectrofluorimetric method for determination of lomefloxacin based on supramolecular inclusion complex between it and p-sulfonated calyx[4]arene, Anal.
Kornea epiteli iyilesene kadar lomefloxacin %3 antibiyotikli goz damlasi (Okacin, Novartis Ophthalmics AG, Hettlingen, Switzerland) ve iki hafta boyunca suni gozyasi damlalari ve topikal fluorometholone recete edildi.
In studies based on isolates from treated patients, GAT along with moxifloxacin was found to be most effective followed by SPX, OFL, CIP and lomefloxacin (11,12,21,34-37).
The newer ones--such as lomefloxacin, sparfloxacin, and trovafloxacin--are better against anaerobes than the older ones.
Proposed criteria for the interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin.
Norfloxacin probably has less effect; neither ofloxacin nor lomefloxacin appears to affect caffeine metabolism.
GNB showed >80% sensitivity to Ceftazidime, Ciprofloxacin, Lomefloxacin, Gentamicin and Netilline.
During the control examination after treatment of hyphema including cyclopentolate 1%, prednisolone acetate 1% and lomefloxacin 0.
Partial susceptibility was observed for quinolones like ofloxacin, sparfloxacin, lomefloxacin and other antibiotics.
Until now, two gylcopeptides (vancomycin and teicoplanin), two carbapenems (imipenem and meropenem), four macrolides (erythromycin, roxithromycin, clarithromycin, and azithromycin), and six quinolones (nalidixic acid, norfloxacin, ofloxacin, lomefloxacin, ciprofloxacin, and levofloxacin) have been available for clinical use in Taiwan.
Gonococcal organisms with decreased in vitro susceptibilities to ciprofloxacin have decreased suseptibilities to all fluoroquinolones, including ofloxacin, enoxacin, lomefloxacin, and norfloxacin (6).